We are committed to continuous improvement, focusing on enhancing our R&D capabilities and implementing cost effective manufacturing processes to maintain our position as a preferred manufacturer with high quality standards. Our derisked business model is supported by multiple pillars: leadership in MCC manufacture, globally; trusted brand across all operational business segments; presence in the entire pharma ecosystem; cutting-edge manufacturing capabilities; and low debt profile, maximising financial stability. Looking ahead, we are optimistic about our growth trajectory and aspire to expand our footprint, improve our customer base and introduce innovative products for our global clientele.